Table 1.
High-Risk Group | Low-Risk Group |
---|---|
Pretransplant HCC24,25 | HBeAg-negative patient52 |
Posttransplant HCC recurrence24,25 | Low serum levels of HBV DNA52 |
HBeAg-positive patient16 | HDV coinfection52 |
HBeAg-negative patient with high serum HBV DNA levels16,21,22 | Fulminant HBV infection18 |
Antiviral drug—resistant strain pretransplant16,21,22 |
HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HDV, hepatitis D virus.